NIPH
TMO icon

NN Investment Partners Holdings’s Thermo Fisher Scientific TMO Stock Holding History

NN Investment Partners Holdings’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$310M Sell
524,845
-35,980
-6% -$20.7M 1.67% 10
2021
Q4 		$374M Buy
560,825
+28,992
+5% +$18.1M 1.87% 8
2021
Q3 		$304M Sell
531,833
-24,304
-4% -$13.3M 1.68% 10
2021
Q2 		$281M Sell
556,137
-50,592
-8% -$23.9M 1.49% 10
2021
Q1 		$277M Sell
606,729
-121,619
-17% -$58M 1.63% 10
2020
Q4 		$339M Sell
728,348
-148,365
-17% -$69.6M 2.06% 7
2020
Q3 		$387M Sell
876,713
-109,268
-11% -$45.1M 2.5% 6
2020
Q2 		$357M Buy
985,981
+17,996
+2% +$6.03M 2.4% 7
2020
Q1 		$275M Sell
967,985
-49,644
-5% -$15.7M 2.24% 8
2019
Q4 		$331M Buy
1,017,629
+1,027
+0.1% +$311K 2.24% 5
2019
Q3 		$296M Buy
1,016,602
+29,132
+3% +$8.34M 2.32% 4
2019
Q2 		$290M Buy
987,470
+162,840
+20% +$44.9M 2.3% 6
2019
Q1 		$226M Sell
824,630
-13,124
-2% -$3.27M 1.76% 9
2018
Q4 		$187M Sell
837,754
-89,635
-10% -$21M 1.59% 10
2018
Q3 		$226M Sell
927,389
-84,160
-8% -$19.4M 1.63% 9
2018
Q2 		$210M Buy
1,011,549
+23,456
+2% +$4.98M 1.53% 9
2018
Q1 		$204M Sell
988,093
-30,576
-3% -$6.42M 1.47% 10
2017
Q4 		$193M Sell
1,018,669
-173,955
-15% -$33.3M 1.37% 11
2017
Q3 		$217M Buy
1,192,624
+606,104
+103% +$110M 1.38% 8
2017
Q2 		$102M Buy
586,520
+57,922
+11% +$9.73M 0.94% 25
2017
Q1 		$81.2M Buy
528,598
+433,898
+458% +$66.3M 0.77% 32
2016
Q4 		$13.4M Buy
94,700
+4,228
+5% +$623K 0.13% 160
2016
Q3 		$14.4M Sell
90,472
-26,503
-23% -$4.08M 0.14% 148
2016
Q2 		$17.3M Buy
116,975
+1,671
+1% +$247K 0.16% 134
2016
Q1 		$16.3M Buy
+115,304
New +$15.5M 0.16% 134

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NN Investment Partners Holdings's TMO Position: Q1 2022 in Review

NN Investment Partners Holdings reduced its Thermo Fisher Scientific (TMO) stake by 6.4% in Q1 2022, selling an estimated $20.7M and leaving 524,845 shares worth $310M. The position accounts for 1.67% of the portfolio, ranked #10.

NN Investment Partners Holdings first reported a position in TMO in Q1 2016 and has held it in 25 quarters since. The position peaked at $387M in Q3 2020. 2,315 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

  • NN Investment Partners Holdings held 524,845 shares of Thermo Fisher Scientific worth $310M as of Q1 2022.
  • NN Investment Partners Holdings sold 35,980 Thermo Fisher Scientific shares in Q1 2022, an estimated $20.7M.
  • Thermo Fisher Scientific made up 1.67% of NN Investment Partners Holdings's portfolio in Q1 2022, its #10 holding.
  • NN Investment Partners Holdings first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 25 quarters since.
  • NN Investment Partners Holdings's Thermo Fisher Scientific position peaked at $387M in Q3 2020.
  • 2,315 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.